Loss of the retinal glycocalyx in diabetes
糖尿病患者视网膜糖萼的丧失
基本信息
- 批准号:9321055
- 负责人:
- 金额:$ 36.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-01 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdhesionsAdultAttenuatedBackBindingBlindnessBlood CirculationBlood VesselsBlood capillariesCD31 AntigensCell AdhesionCell surfaceCessation of lifeCleaved cellClinicalDevelopmentDiabetes MellitusDiabetic RetinopathyDiseaseDockingDropoutEmigrationsEndothelial CellsEndotheliumEnzymesExperimental ModelsExtracellular DomainGlycocalyxGlycoproteinsGlycosaminoglycansGlypicanHealthHemorrhageHeparan Sulfate ProteoglycanHeparitin SulfateHypoxiaIndividualLeadLeukocyte Adhesion MoleculesLeukocyte-Adhesion ReceptorsLeukocytesMatrix MetalloproteinasesMechanicsMediatingMicroaneurysmMicrocirculationMicrovascular DysfunctionModelingNitric OxidePathologyPermeabilityPlasmaProductionProteoglycanRetinaRetinalRoleSamplingSignal TransductionSiteSurfaceTestingThickThrombosisTissuesTubeVisionangiogenesiscapillarycotton wool spotscytokinediabeticheparanaseneovascularizationpreventreceptorretina blood vessel structureshear stresssyndecan
项目摘要
Diabetic retinopathy, the leading cause of blindness in adults, is recognized as a microvascular complication of
the disease, with retinal microvessels characterized by microaneurysms, leukocyte-endothelial cell adhesion,
hemorrhages, increased permeability, capillary occlusion, neovascularization, etc. We propose that an
underlying contributor to the retinal pathology is the loss of the endothelial surface layer (glycocalyx). The
glycocalyx is a dense layer of molecules including proteoglycans (e.g., syndecan-1) and glycosaminoglycans
(GAGs, e.g., heparan sulfate). The glycocalyx facilitates the interactions between plasma molecules and their
endothelial receptors, inhibits thrombosis, shields against leukocyte-endothelial cell adhesion, transduces
shear force, and acts as a permeability barrier. Inasmuch as heparan sulfate can be cleaved by heparanase,
and syndecan-1 has multiple sites on its extracellular domain susceptible to cleavage by matrix
metalloproteinases (MMPs), we hypothesize a role for these enzymes in the loss of the glycocalyx in diabetes.
With a combined attack on both syndecan-1 and heparan sulfate, the functions of the glycocalyx could be
substantially lost, which has been shown in many models to enhance leukocyte-endothelial cell adhesion.
Such adhesion is thought to promote the occlusion of capillaries in the diabetic retina, leading to the
subsequent development of “acellular” capillaries that are no longer perfused, creating ischemic zones.
Ultimately, the resulting hypoxia promotes uncontrolled angiogenesis that interferes with clear vision. When a
leukocyte adheres to the endothelial surface, it can eventually be coerced back into the bloodstream by shear
forces, or alternatively, cross the endothelium (emigrate) into the surrounding tissue in a mechanism mediated
by platelet endothelial cell adhesion molecule-1 (PECAM-1). However, loss of PECAM-1 prevents leukocyte
emigration, and adherent leukocytes can be trapped within capillaries causing continued occlusion and
eventual capillary death. We and others have noted a loss of PECAM-1 from the diabetic retinal
microcirculation, with this loss possibly caused by mechanisms such as MMP-mediated cleavage, cytokine-
mediated decrease in production, and/or proteasomal degradation. The following specific aims address the
overall hypothesis that diabetes induces the loss of key endothelial surface molecules that results in leukocyte
adhesion, capillary occlusion, and eventual development of acellular capillaries: (1) Investigate the hypothesis
that the loss of heparan sulfate from the diabetic retinal microcirculation is mediated directly by heparanase
and indirectly by MMP-facilitated cleavage of syndecan-1, (2) Determine the mechanism(s) responsible for the
loss of PECAM-1 from the diabetic retinal microcirculation, by testing for decreased expression, increased
proteasomal degradation, and cleavage from the endothelial cell surface, and (3) Investigate the hypothesis
that capillary occlusion by leukocytes and the development of acellular capillaries can be attenuated by
protection of the endothelial surface layer.
糖尿病视网膜病变是成人失明的主要原因,被认为是糖尿病的微血管并发症
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NORMAN R HARRIS其他文献
NORMAN R HARRIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NORMAN R HARRIS', 18)}}的其他基金
Retinal blood flow regulation in early diabetes
早期糖尿病的视网膜血流调节
- 批准号:
8182567 - 财政年份:2007
- 资助金额:
$ 36.25万 - 项目类别:
Retinal blood flow regulation in early diabetes
早期糖尿病的视网膜血流调节
- 批准号:
8721962 - 财政年份:2007
- 资助金额:
$ 36.25万 - 项目类别:
Retinal blood flow regulation in early diabetes
早期糖尿病的视网膜血流调节
- 批准号:
8528604 - 财政年份:2007
- 资助金额:
$ 36.25万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 36.25万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 36.25万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 36.25万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 36.25万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 36.25万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 36.25万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 36.25万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 36.25万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 36.25万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 36.25万 - 项目类别:














{{item.name}}会员




